创新药2025H1业绩综述:看好盈利改善 估值突破

浙商证券
Sep 24, 2025

1、复盘:股价强势,盈利改善股价:BD驱动是主线,临床数据和业绩配合。A股(2024.12.31-2025.9.8)荣昌生物(+208.87%)>益方生物(+188.72%)>迈威生物(+165.35%)>诺诚健华(+123.05%)>康弘药业(+106.10%),H股(2024.12.31-2025.9.15)荣昌生物(+666.67%)>三生制药(+430.55%)>科伦博泰生物(+...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10